QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.105.090456v1 315/2/722    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hermenegildo, C. Articles by Cano, A. Search for Related Content PubMed PubMed Citation Articles by Hermenegildo, C. Articles by Cano, A.

CARDIOVASCULAR

Effects of Phytoestrogens Genistein and Daidzein on Prostacyclin Production by Human Endothelial Cells

Research Unit, Hospital Clínico Universitario of Valencia, Valencia, Spain (C.H., M.A.G.-P.); and Departments of Physiology (C.H.), Pediatrics, Obstetrics, and Gynecology (P.J.O., A.C.), and Functional Biology and Physical Anthropology (J.J.T.), University of Valencia, Valencia, Spain

The molecular mechanisms of the vascular effects of phytoestrogens are poorly studied. Prostacyclin is a potent vasodilator synthesized by two isoforms of cyclooxygenase (COX) in endothelium. This study examine the effects of two phytoestrogens, the isoflavones genistein and daidzein, on prostacyclin production by cultured human umbilical vein endothelial cells (HUVECs) and the possible role of not only estrogen receptors but also both COX isoforms. The two phytoestrogens significantly increased prostacyclin release in a time- and dose-dependent (0.01-1 µM) manner, being higher than control after 24 h. Selective inhibitors of COX-1, SC-560 [5-(4-chlorophenyl)-1-(4-methoxypjenyl)-3-(trifluoromethyl)-1H-pyrazole], and COX-2, NS-398 (N-[2-(cyclohexyloxy)-4 nitrophenyl]-methanesulfonamide), were used to investigate the relative contribution of each enzyme. Both inhibitors decreased basal production of prostacyclin, but only COX-2 inhibition completely abolished the isoflavone-stimulated prostacyclin production. Phytoestrogens also increased COX-2 mRNA expression and protein content without affecting COX-1 levels. All these effects were mediated through estrogen receptor activation since treatment of cells with the estrogen receptor antagonist ICI 182780 [7-[9[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17 diol] completely abolished the isoflavone-induced increase in prostacyclin production, COX-2 mRNA expression, and COX-2 protein content. The results clearly support the hypothesis that genistein and daidzein increased HUVEC prostacyclin production through estrogen receptor-dependent mechanism, which involved the enhancement of COX-2 protein and activity.

Address correspondence to: Dr. Carlos Hermenegildo, Research Unit, Faculty of Medicine and Dentistry, Av. Blasco Ibañez, 17, E 46010 Valencia, Spain. E-mail: carlos.hermenegildo{at}uv.es

This article has been cited by other articles:

				J.-I. SHIN, Y.-K. LEE, Y. M. KIM, J.-T. HWANG, and O. J. PARK Possible Link Between NO Concentrations and COX-2 Expression in Systems Treated with Soy-Isoflavones Ann. N.Y. Acad. Sci., January 1, 2007; 1095(1): 564 - 573. [Abstract] [Full Text] [PDF]

				E. Monsalve, P. J. Oviedo, M. A. Garcia-Perez, J. J. Tarin, A. Cano, and C. Hermenegildo Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells Cardiovasc Res, January 1, 2007; 73(1): 66 - 72. [Abstract] [Full Text] [PDF]